Table 3.
Comparisons of Clinical Variables Between Groups
| Bleeding Group | Non-Bleeding Group | P | |
|---|---|---|---|
| Age | <0.001a | ||
| Children | 22 | 181 | |
| Adults | 23 | 608 | |
| Sex | 0.146a | ||
| Male | 26 | 368 | |
| Female | 19 | 421 | |
| Passes of biopsy | 0.009a | ||
| 1 | 29 | 635 | |
| ≥2 | 16 | 154 | |
| Biopsy target | 0.877a | ||
| Focal lesion | 6 | 99 | |
| Liver parenchyma | 39 | 690 | |
| HbsAg | 0.421a | ||
| Positivity | 2 | 72 | |
| Negativity | 43 | 717 | |
| ALT | 62.00(18.50, 163.00) | 39.00(21.00, 92.00) | 0.236b |
| ALT/AST | 1.07(0.79, 1.88) | 1.00(0.73, 1.45) | 0.119b |
| T-BIL | 17.02(9.33, 49.47) | 14.93(10.11, 24.59) | 0.228b |
| Platelet Count | 148.00(103.00, 214.50) | 204.00(145.00, 259.00) | 0.002b |
| PT | 12.60(11.60, 13.55) | 11.70(11.20, 12.50) | <0.001b |
| INR | 1.11(1.04, 1.25) | 1.04(0.97, 1.13) | <0.001b |
Notes: aχ2 test; bMann–Whitney U-test.
Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; T-BIL, total bilirubin; HbsAg, hepatitis B surface antigen; INR, international normalized ratio; PT, prothrombin time.